Favourable risk patient case study video

Bavencio®▼ (avelumab) + axitinib: Clinical experience in advanced RCC.

For BAVENCIO® (avelumab) + axitinib prescribing information and adverse event reporting, click here.

For SUTENT® (sunitinib malate) prescribing information and adverse event reporting, click here.

 

GB-AVEKI-00241 | PP-BAV-GBR-0601. January 2021